Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $92.5 million.

  • Korro Bio's Cash & Current Investments fell 3249.56% to $92.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.5 million, marking a year-over-year decrease of 3249.56%. This contributed to the annual value of $126.1 million for FY2024, which is 2571.72% down from last year.
  • Latest data reveals that Korro Bio reported Cash & Current Investments of $92.5 million as of Q3 2025, which was down 3249.56% from $96.4 million recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Cash & Current Investments ranged from a high of $194.9 million in Q1 2021 and a low of $41.7 million during Q3 2023
  • Its 5-year average for Cash & Current Investments is $116.7 million, with a median of $117.4 million in 2022.
  • In the last 5 years, Korro Bio's Cash & Current Investments tumbled by 5813.4% in 2023 and then surged by 23872.8% in 2024.
  • Quarter analysis of 5 years shows Korro Bio's Cash & Current Investments stood at $130.7 million in 2021, then tumbled by 57.73% to $55.2 million in 2022, then surged by 207.25% to $169.8 million in 2023, then fell by 25.72% to $126.1 million in 2024, then dropped by 26.66% to $92.5 million in 2025.
  • Its Cash & Current Investments stands at $92.5 million for Q3 2025, versus $96.4 million for Q2 2025 and $115.0 million for Q1 2025.